The Trump administration's recent announcement that hundreds of baby formula samples meet a high safety standard is drawing sharp pushback from independent scientists and public health advocates who say the data tells a starkly different story.
Under a testing initiative called Operation Stork Speed, the FDA examined 300 baby formula samples for a range of dangerous substances including Pfas, phthalates, lead, pesticides, and mercury. The results revealed contamination that contradicts the administration's rosy framing. At least half of all samples contained Pfos, one of the most hazardous Pfas compounds, for which federal authorities have determined no safe exposure level exists in drinking water. About half also contained phthalates, chemicals used to make plastic flexible that readily leach into food.
Department of Health and Human Services Secretary Robert F. Kennedy Jr. stated that "most products meet a high safety standard" and pledged to "hold manufacturers accountable." The announcement provided no details about what steps would follow.
But the fine print reveals a troubling reality. The FDA's own 2014 research documented how even small amounts of these chemicals pose serious risks to newborns whose developing bodies and higher food-to-body-weight ratios make them uniquely vulnerable. Independent experts say the current testing data flatly contradicts this established science.
Maricel Maffini, a regulatory consultant, expressed alarm at the prevalence of endocrine disrupting chemicals like phthalates and Pfas. These compounds interfere with hormonal development at critical stages, potentially causing developmental, reproductive, and neurological damage that can manifest immediately or later in life. "There is no really safe amount of endocrine disruptors," Maffini said, challenging the administration's assertion that low doses pose minimal risk.
The FDA reported that 95 percent of Pfos levels fell below 2.9 parts per trillion, citing this as reassurance. But drinking water standards are set at 4 ppt, and experts question whether those thresholds adequately protect infants. Research has linked even low-level Pfas exposure during pregnancy and infancy to diminished immune function.
Critical gaps in the testing data compound the problem. The FDA did not publicly identify which specific products contain which contaminants, leaving parents unable to make informed choices. The agency also failed to disclose whether individual samples contained multiple contaminants. While limited research exists on simultaneous exposure to several chemicals, scientific consensus suggests the effects may be additive or synergistic, amplifying harm.
Tasha Stoiber, a scientist with the Environmental Working Group, noted that dry formulas must be reconstituted with water that may itself contain Pfas, potentially increasing toxicity. The short-chain Pfas compounds detected in the formulas are widely used throughout the food system. "When there is widespread use of Pfas, this is the result," Stoiber said.
Phthalates, found in 46 percent of samples, almost certainly originate from plastic packaging and processing equipment. Despite this known danger, the FDA has set no enforceable limit on phthalates, established a safe daily intake level, or issued meaningful guidance on the chemicals' use in food production.
One bright spot emerged from the testing. Lead and metal contamination, which has plagued baby formula for years, showed lower levels than in previous snapshots, suggesting regulatory pressure on manufacturers is having some effect. Tom Neltner, director of the Unleaded Kids nonprofit, acknowledged the administration's expansion of testing and praised the FDA for making results public. But he warned the data represents only a snapshot in time. Without ongoing transparency and enforceable action levels for lead, companies have no assurance they will maintain current contamination standards.
New legislation introduced in California and Vermont would require formula manufacturers to publicly share their own testing results. The FDA has long claimed it lacks authority to view industry testing data, a position Neltner disputes. He called the administration's next step critical: establishing an action level for lead that does not yet exist.
FDA Commissioner Marty Makary called the results "encouraging" and noted that how a society treats its most vulnerable members reflects its character. Yet the very data his agency released suggests that character is currently failing infants exposed to chemicals at doses the government's own prior research identified as unsafe.
Author James Rodriguez: "Declaring contaminated formula safe because the contamination levels are merely low instead of very high is a dangerous game of semantics that puts the most vulnerable children at risk."
Comments